XXII
22nd Century Group, Inc.
NASDAQ · Consumer Defensive · Tobacco · US
$0.04
−16.36%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$0.04
From 52W high−99.99%
Volume41.18M
Market cap$775768.80
P/E (TTM)—
P/S (TTM)0.1x
Div yield—
Key dataNov 4, 2026
Open
$0.04
From 52W high
−99.99%
Volume
41.18M
Market cap
$775768.80
ValuationView details →
P/E (Fwd)
0.0x
EV/EBITDA
0.4x
P/E (TTM)
—
RSI (14)
16.7
MomentumView details →
1D Return
−16.36%
YTD Return
−99.98%
SummaryUpdated Jun 1, 2026
22nd Century Group, Inc. (NASDAQ:XXII) is an agricultural biotechnology company founded in 1998 and headquartered in Buffalo, New York. The company went public in 2011 and has undergone significant strategic transformation over its history. Originally focused on developing genetically modified tobacco plants with altered nicotine content, the company expanded into hemp and cannabis biotechnology before recently divesting those operations to refocus exclusively on tobacco products. Today, 22nd Century operates as a pure-play tobacco company specializing in reduced nicotine cigarettes and contract manufacturing services for other tobacco companies.
Similar companies
Latest newsMore news →
22nd Century Group announced that it will release its third-quarter 2026 results on November 16, 2026, and host a webcast at 8:00 a.m. ET to discuss them.1d ago22nd Century Group, Inc. signed an agreement with Gopuff to offer Pinnacle VLN and Pinnacle Pure on Gopuff’s nationwide direct-to-consumer on-demand platform.6d ago22nd Century Group preliminarily reported third-quarter 2026 revenue of $4.8 million, up 66%, and gross profit of $0.4 million, compared with a loss in the prior-year period.13d ago